✦ LIBER ✦

High-dose carboplatin plus paclitaxel with granulocyte colony-stimulating factor and peripheral blood stem-cell support in non-small-cell lung cancer

✍ Scribed by T. C. Shea

Publisher: Springer
Year: 1997
Tongue: English
Weight: 115 KB
Volume: 40
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800051066

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose escalation study of carboplatin wit

Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma: A study of the lung cancer study group of west Japan

✍ Nobuyuki Katakami; Minoru Takada; Shunichi Negoro; Katsuyasu Ota; Jiro Fujita; K 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

## BACKGROUND. We performed a Phase 1-11 trial to determine the maximum tolerated dose of carboplatin (CBDCA) with a fixed dose of VP-16 and granulocyte-colony stimulating factor (G-CSF) in small cell lung cancer (SCLC) patients. ## METHODS. Treatment consisted of a starting dose of CBDCA, 400

Granulocyte-macrophage colony-stimulatin

Granulocyte-macrophage colony-stimulating factor increases dose intensity of chemotherapy in small cell lung cancer: Relationship between clinical results, peripheral blood cell modifications, and bone marrow kinetics

✍ Adriano Paccagnella; Adolfo Favaretto; Alberto Riccardi; Marco Danova; Cristina 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 983 KB

Phase II study of intensive chemotherapy

Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer

✍ Giorgio Vittorio Scagliotti; Umberto Ricardi; Lucio Crinó; Ernesto Maranzano; Fi 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 375 KB

A phase II study of irinotecan and infus

A phase II study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer

✍ Kiyoshi Mori; Suguru Machida; Takeshi Yoshida; Munehide Yoshida; Yasuliko Kano; 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 68 KB

Beneficial impact of peripheral blood pr

Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor a randomized trial

✍ Alan Kritz; John P. Crown; Robert J. Motzer; Lilian M. Reich; Glenn Heller; Mich 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

Docetaxel and granulocyte colony-stimula

Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial

✍ K. Alexopoulos; C. Kouroussis; N. Androulakis; E. Papadakis; M. Vaslamatzis; S. 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 90 KB